| Financial Year |
March 31 2023 |
| Monetary Funds |
52,587,347.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
28,786,819.29 |
| Advances to Suppliers |
36,964,518.35 |
| Other Receivables |
4,340,540.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
263,021,549.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,589,490.39 |
| Total Current Assets |
436,563,636.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
486,484,613.52 |
| Under-construction Projects |
11,687,749.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,406,067.75 |
| R&D expenses |
-- |
| Goodwill |
210,016,574.07 |
| Long-Term Deferred and Prepaid Expenses |
26,415.26 |
| Deferred Income Tax Assets |
1,430,116.97 |
| Other Non-Current Assets |
3,143,625.57 |
| Sub-Total of Non-Current Assets |
803,300,532.86 |
| Total Assets |
1,239,864,169.72 |
| Short-Term Loans |
205,351,494.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
48,817,306.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,758,100.14 |
| Taxes Payable |
1,196,690.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,804,834.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
763,807,184.95 |
| Other Current Liabilities |
1,782,783.36 |
| Sub-Total of Current Liabilities |
1,084,758,831.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,988,224.07 |
| Deferred Income Tax Liabilities |
6,565,563.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,675,221.42 |
| Total Liabilities |
1,108,434,052.43 |
| Paid-In Capital(Or Share Stock) |
1,071,274,605.00 |
| Capital Surplus |
882,549,887.15 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,692,464,230.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
131,430,117.29 |
| Owner's Equity（Stockholder's Equity） |
131,430,117.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,239,864,169.72 |
